Telix Pharmaceuticals Ltd. (TLPPF)
OTHER OTC:TLPPF
Holding TLPPF?
Track your performance easily

Telix Pharmaceuticals Ltd. (TLPPF) Financial Statements

70 Followers

Telix Pharmaceuticals Ltd. Financial Overview

Telix Pharmaceuticals Ltd.'s market cap is currently ―. The company's EPS TTM is $0.098; its P/E ratio is 134.31; Telix Pharmaceuticals Ltd. is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 116.33MAU$ 22.04MAU$ 77.94MAU$ 44.60MAU$ 25.77M
Total AssetsAU$ 255.35MAU$ 109.81MAU$ 157.82MAU$ 102.61MAU$ 76.71M
Total DebtAU$ 10.45MAU$ 2.54MAU$ 2.21MAU$ 2.13MAU$ 1.73M
Net DebtAU$ -105.88MAU$ -19.50MAU$ -75.74MAU$ -42.47MAU$ -24.04M
Total LiabilitiesAU$ 175.35MAU$ 107.66MAU$ 78.81MAU$ 32.53MAU$ 23.80M
Stockholders EquityAU$ 80.01MAU$ 2.16MAU$ 79.02MAU$ 70.08MAU$ 52.90M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Telix Pharmaceuticals Ltd. Earnings and Revenue History

Telix Pharmaceuticals Ltd. Debt to Assets

Telix Pharmaceuticals Ltd. Cash Flow

Telix Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis